NCT04064125View on ClinicalTrials.gov

Dermal Cumulative Irritant Patch Study

PHASE1CompletedINTERVENTIONAL

Enrollment

42

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

September 28, 2016

Study Completion Date

October 28, 2016

Conditions

Healthy

Interventions

DRUG

FMX-101

All Listed Sponsors

lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04064125 - Dermal Cumulative Irritant Patch Study | Biotech Hunter | Biotech Hunter